Guided Therapeutics (GTHP) Profit After Tax (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly Profit After Tax came in at -$605000.0 in Q2 2026, up 25.4% year-over-year from -$482453.3 in Q2 2025, and down 21.0% quarter-over-quarter from -$500000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Profit After Tax (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Profit After Tax across 17 years of filings, most recently posting -$605000.0 for Q2 2026.
- In Q2 2026, Profit After Tax rose 25.4% year-over-year to -$605000.0; the TTM figure through Jun 2026 stood at -$3.1 million (down 20.48% YoY), while the FY2025 annual figure was -$3.2 million, down 32.23% from the prior year.
- Profit After Tax came in at -$605000.0 for Q2 2026 at Guided Therapeutics, down from -$500000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$402.0 in Q1 2024 to a low of -$1.8 million in Q4 2022.
- Average Profit After Tax over 5 years is -$786077.9, with a median of -$693000.0 recorded in 2023.
- Year-over-year, Profit After Tax jumped 99.95% in 2024 and tumbled 106118.91% in 2025.
- Over 5 years, Profit After Tax stood at -$1.8 million in 2022, then surged by 78.64% to -$386000.0 in 2023, then plunged by 68.91% to -$652000.0 in 2024, then slumped by 86.81% to -$1.2 million in 2025, then soared by 50.33% to -$605000.0 in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$605000.0 in Q2 2026, -$500000.0 in Q1 2026, and -$1.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | -605,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -605,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | -742,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Mar 31, 2025 | -427,000.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | -709,000.00 |
| Mar 31, 2024 | -402.00 |
| Dec 31, 2023 | -386,000.00 |
| Sep 30, 2023 | -677,000.00 |
| Jun 30, 2023 | -1.56 Mn |
| Mar 31, 2023 | -869,000.00 |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | -926,000.00 |
| Mar 31, 2022 | -507,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | 68,000.00 |